Home › Funds › DEARBORN PARTNERS LLC › JNJ

DEARBORN PARTNERS LLC position in JNJ

JOHNSON & JOHNSON · Health Care

DEARBORN PARTNERS LLC reported holding 79,306 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$21.0M, representing 1.28% of its reported portfolio and ranking #28 among its reported holdings. DEARBORN PARTNERS LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)79.31K sh
Reported value held$21.00M
Portfolio Weight1.28%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DEARBORN PARTNERS LLC's JNJ position evolved

DEARBORN PARTNERS LLC first disclosed a stake in JNJ in Q3 2023 at 112,299 shares (US$17.5M). The position peaked in Q3 2026 at 79,306 shares, worth US$21.0M. Across 13 filings, DEARBORN PARTNERS LLC increased the stake 0 time(s), trimmed it 9 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 79,306 shares valued at US$21.0M — a reduction of -589 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 112.30K $17.49M New
Q4 2023 111.86K $17.53M Hold
Q1 2024 111.22K $17.59M Reduce
Q2 2024 109.55K $16.01M Reduce
Q3 2024 108.98K $17.66M Reduce
Q4 2024 108.77K $15.73M Hold
Q1 2025 107.83K $17.88M Reduce
Q2 2025 82.73K $12.64M Reduce
Q3 2025 81.91K $15.19M Reduce
Q4 2025 80.93K $16.75M Reduce
Q1 2026 79.86K $19.52M Reduce
Q2 2026 79.89K $20.29M Hold
Q3 2026 79.31K $21.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has DEARBORN PARTNERS LLC held JNJ?

DEARBORN PARTNERS LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DEARBORN PARTNERS LLC's current position in JNJ?

As of Q3 2026, DEARBORN PARTNERS LLC holds 79.31K shares of JNJ (JOHNSON & JOHNSON), valued at $21.00M, representing 1.28% of its reported portfolio and ranking #28.

Has DEARBORN PARTNERS LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), DEARBORN PARTNERS LLC reduced its position in JNJ. The position peaked in Q3 2026 at 79.31K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.